Author

Moumita Karmakar

Texas A&M University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Organism:rat· 1

Frequent Co-Authors

Anuhya S. KottaiD· 1 shared Erin Danielle GilesiD· 1 shared Jenna L. Strandmo· 1 shared Karen A. CorletoiD· 1 shared Nanci Lammoglia· 1 shared Paul S. MacLeaniD· 1 shared Pepper S. SchediniD· 1 shared Raymond James CarrolliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anuhya S. KottaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting the menopause transition with metformin improves breast cancer outcomes, but discontinuation has deleterious effects on metabolic health: Findings from a preclinical model of postmenopausal breast cancer.

Karen A. Corleto, Pepper S. Schedin, Anuhya S. Kotta, Jenna L. Strandmo, Samantha Foster, Nanci Lammoglia, Moumita Karmakar, Raymond James Carroll, Paul S. MacLean, Erin Danielle Giles

This study shows that metformin reduces breast cancer in rats during early postmenopause but discontinuation harms metabolic health, linking timing of treatment to cancer and metabolic outcomes.

bioRxiv · Nov 25, 2024 · PreprintCancer Biology